Skip to main content
Veterinary Medicines

Тylosin 50% WSP

Authorised
  • Tylosin tartrate

Product identification

Medicine name:
Тилозин 50% водоразтворим прах
Тylosin 50% WSP
Active substance:
  • Tylosin tartrate
Target species:
  • Pig
  • Chicken (broiler)
  • Turkey
  • Chicken (chick, for replacement)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Tylosin tartrate
    500000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        6
        day
    • Chicken (broiler)
      • Meat and offal
        4
        day
    • Turkey
      • Meat and offal
        6
        day
    • Chicken (chick, for replacement)
      • Meat and offal
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA90
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zavet AD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zavet AD
Responsible authority:
  • BFSA
Authorisation number:
  • 0022-2161/17.01.2014
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 23/05/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 23/05/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."